The effects of carbamazepine and levetiracetam on serum prothrombin time (PT), activated partial thromboplastin time (APTT), and D-dimer (D-D) levels and fibrinogen (FIB)
serum prothrombin time (PT), activated partial thromboplastin time (APTT), and D-dimer (D-D) levels and fibrinogen (FIB)
Abstract
Introduction: epilepsy is a common neurological disorder, so exploring its treatment programs is of high significance. In this content, this work was developed to compare the effects of monotherapy with Carbamazepine (CBZ) and Levetiracetam (LEV) on coagulation factors and disease control in patients with partial-onset epilepsy (POE). Materials and Methods: in this work, 89 patients with POE diagnosed and treated at our hospital from January 2023 to January 2024 were enrolled. The patients were rolled into the CBZ group and the LEV group. Blood coagulation parameters were measured before and after treatment, and the frequency and severity of epileptic seizures were recorded for patients in different groups. Results: regarding coagulation factors, in the CBZ group, prothrombin time (PT), activated partial thromboplastin time (APTT), and D-dimer (D-D) levels at 1, 3, and 6 months after treatment were sharply lower in contrast to the pre-treatment levels, while changes in the LEV group were not obvious. Meanwhile, the fibrinogen (FIB) content after treatment was decreased in both groups. Furthermore, the frequency of epileptic seizures in all patients was reduced greatly after treatment, and difference in the control rate of frequency of epileptic seizure was not greatly different for patients in different groups. Conclusion: CBZ may increase the risk of coagulation abnormalities, but it was highly effective in controlling epileptic seizures. However, LEV had a smaller impact on coagulation and exhibited similar effect in controlling epileptic seizures.
References
Chen WY, Lv XY, Rong RM, Wu BT (2021) Carbamazepine-induced immune thrombocytopenia confirmed by modified MASPAT test. Transfus Apher Sci 60(6):103228(1-2).
Cioriceanu IH, Constantin DA, Bobescu E, Marceanu LG, Rogozea L (2023) Influence of clinical factors on the quality of life in romanian people with epilepsy-a follow-up study in real-life clinical practice. J Pers Med 13(5):752(1-7).
Felisbino MB, Ziemann M, Khurana I, Okabe J, Al-Hasani K, Maxwell S, Harikrishnan KN, de Oliveira CBM, Mello MLS, El-Osta A (2021) Valproic acid influences the expression of genes implicated with hyperglycaemia-induced complement and coagulation pathways. Sci Rep 11(1):2163(1-12).
Gallego MDC, García MA (2022) Acute Carbamazepine intoxication. Neurol Int 14(3):614-618.
Huang QJ, Liu JG, Shi ZX, Zhu XH (2020) Correlation of MMP-9 and HMGB1 expression with the cognitive function in patients with epilepsy and factors affecting the prognosis. Cell Mol Biol (Noisy-le-grand) 66(3):39-47.
Jawaid W (2023) For the love of all that is holy, stop prescribing sodium valproate and carbamazepine together. Pak J Med Sci 39(1):314.
Kanner AM, Bicchi MM (2022) Antiseizure medications for adults with epilepsy: a review. JAMA-J Am Med Assoc 327(13):1269-1281.
Kharel S, Ojha R, Khanal S (2022) Levetiracetam versus oxcarbazepine as monotherapy in newly diagnosed focal epilepsy: a systematic review and meta-analysis. Brain Behav 12(11): e2779(1-8).
Kośmider K, Kamieniak M, Czuczwar SJ, Miziak B (2023) Second generation of antiepileptic drugs and oxidative stress. Int J Mol Sci 24(4):3873(1-18).
Latimer D, Le D, Falgoust E, Ingraffia P, Abd-Elsayed A, Cornett EM, Singh R, Choi J, Varrassi G, Kaye AM, Kaye AD, Ganti L (2023) Brivaracetam to treat partial onset seizures in adults. Health Psychol Res 10(5):56782(1-13).
Li XL, Zhou R, Peng H, Peng J, Li QL, Mei M (2023) Microglia PKM2 mediates neuroinflammation and neuron loss in mice epilepsy through the astrocyte C3-Neuron C3R signaling pathway. Brain Sci 13(2):262(1-19).
Liparoti G, Burchiani B, Mencaroni E, Tripodi D, Di Cara G, Verrotti A (2022) Individualizing doses of antiepileptic drugs. Expert Opin Drug Metab Toxicol 18(3):219-233.
Madireddy S, Madireddy S (2023) Therapeutic strategies to ameliorate neuronal damage in epilepsy by regulating oxidative stress, mitochondrial dysfunction, and neuroinflammation. Brain Sci 13(5):784(1-27).
Myers KA (2022) Genetic Epilepsy Syndromes. Continuum (Minneap Minn) 28(2):339-362.
Novais F, Andrea M, Andrade G, Loureiro S, Pimentel J, Câmara Pestana L, Epilepsy Surgery Group of Hospital de Santa Maria CHULN (2022) Intelligence quotient (IQ) as a predictor of epilepsy surgery outcome. Epilepsy Behav 132:108708(1-4).
Oguni H (2022) Epilepsy with myoclonic-atonic seizures, also known as Doose syndrome: Modification of the diagnostic criteria. Eur J Paediatr Neurol 36:37-50.
Olaizola I, Brodde MF, Kehrel BE, Evers S (2023) The Impact of Levetiracetam and Valproate on Platelet Functions-A Double-Blind, Placebo-Controlled Crossover Study. J Clin Med 12(3):933(1-8).
Pazarlar BA, Aripaka SS, Petukhov V, Pinborg L, Khodosevich K, Mikkelsen JD (2022) Expression profile of synaptic vesicle glycoprotein 2A, B, and C paralogues in temporal neocortex tissue from patients with temporal lobe epilepsy (TLE). Mol Brain 15(1):45(1-10).
Riney K, Bogacz A, Somerville E, Hirsch E, Nabbout R, Scheffer IE, Zuberi SM, Alsaadi T, Jain S, French J, Specchio N, Trinka E, Wiebe S, Auvin S, Cabral-Lim L, Naidoo A, Perucca E, Moshé SL, Wirrell EC, Tinuper P (2022) International league against epilepsy classification and definition of epilepsy syndromes with onset at a variable age: position statement by the ILAE task force on nosology and definitions. Epilepsia 63(6):1443-1474.
Rugg-Gunn F, Miserocchi A, McEvoy A (2020) Epilepsy surgery. Pract Neurol 20(1):4-14.
Siniscalchi A, Mintzer S, De Sarro G, Gallelli L (2021) Myotoxicity induced by antiepileptic drugs: could be a rare but serious adverse event? Psychopharmacol Bull 51(4):105-116.
Steriade C, Titulaer MJ, Vezzani A, Sander JW, Thijs RD (2021) The association between systemic autoimmune disorders and epilepsy and its clinical implications. Brain 144(2):372-390.
Su WL, Lu HT, Li QD, Tang ZQ, Dang H, Han KY, Li H, Liu Y, Zhang H (2023) Characteristics of cognition impairment in patients after stroke based on the Wechsler Adult Intelligence Scale-Revised in China. Appl Neuropsychol Adult 30(5):1-8.
Takeda Y, Sakakibara T, Ogiwara K, Nogami K (2022) Blood coagulation dynamics during adrenocorticotropic hormone therapy in pediatric patients with infantile spasms. Brain Dev 44(8):546-550.
Thomas SV, Salim S, Jacob NS, Jose M, Salini RA, Selvaraj S, Gomez TS, Sreedharan H, Jeemon P (2022) Language, intelligence, and educational outcomes of adolescents with antenatal exposure to antiseizure medications: Prospective data from the Kerala Registry of epilepsy and pregnancy. Seizure 100:76-81.
Willems LM, van der Goten M, von Podewils F, Knake S, Kovac S, Zöllner JP, Rosenow F, Strzelczyk A (2023) Adverse Event profiles of antiseizure medications and the impact of coadministration on drug tolerability in adults with epilepsy. CNS Drugs 37(6):531-544.
Xie MG, Qiao J, Wang XF, Zhou J, Guan YG, Liu CQ, Zhao M, Li TF, Luan GM (2022) The cognitive functions and seizure outcomes of patients with low-grade epilepsy-associated neuroepithelial tumors. J Neuro-Oncol 160(1):1-12.
Yang HJ, Shi WX, Fan JJ, Wang XS, Song YJ, Lian YJ, Shan W, Wang Q (2023) Transcutaneous auricular vagus nerve stimulation (ta-VNS) for treatment of drug-resistant epilepsy: a randomized, double-blind clinical trial. Neurotherapeutics 20(3):870-880.
Ye Z, Guan XM, Shan WY, Ma BJ (2023) Tripchlorolide inhibits microglial activation by modulating STING-NLRP3 signaling pathway in pilocarpine-induced status epilepticus model. J Biol Regul Homeost Agents 37(6):3123-3129.
Copyright (c) 2025 Guanji Bian
This work is licensed under a Creative Commons Attribution 4.0 International License.
The published articles will be distributed under the Creative Commons Attribution 4.0 International License (CC BY). It is allowed to copy and redistribute the material in any medium or format, and remix, transform, and build upon it for any purpose, even commercially, as long as appropriate credit is given to the original author(s), a link to the license is provided and it is indicated if changes were made. Users are required to provide full bibliographic description of the original publication (authors, article title, journal title, volume, issue, pages), as well as its DOI code. In electronic publishing, users are also required to link the content with both the original article published in Journal of Medical Biochemistry and the licence used.
Authors are able to enter into separate, additional contractual arrangements for the non-exclusive distribution of the journal's published version of the work (e.g., post it to an institutional repository or publish it in a book), with an acknowledgement of its initial publication in this journal.